Related Experiment Video
Updated: Sep 26, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Type 2 Diabetes Mellitus with HbJ trait: A management conundrum
Wan Natrah Wan Yaacob1, Lili Husniati Yaacob2, Nani Draman3
1MBBS (Manipal), MMed Fam Med (USM), Department of Family Medicine, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Optimal glycaemic control is vital for diabetes mellitus (DM) management. Haemoglobin A1c (HbA1c) testing is unreliable in patients with haemoglobinopathies, necessitating alternative monitoring methods for accurate diabetes care.
Area of Science:
- Endocrinology
- Clinical Chemistry
Background:
- Optimal glycaemic control is essential for managing diabetes mellitus (DM) and preventing complications.
- Haemoglobin A1c (HbA1c) is a key biomarker for assessing long-term glycaemic control.
- Haemoglobinopathies can interfere with the accuracy of HbA1c measurements.
Observation:
- This case report details a patient with type 2 DM and a haemoglobin J (HbJ) trait.
- The patient exhibited erratic HbA1c values during routine follow-up.
- This unreliability highlights a challenge in managing DM in individuals with specific haemoglobin variants.
Findings:
- HbA1c testing is unreliable for assessing glycaemic control in patients with haemoglobinopathies, such as the HbJ trait.
- Erratic HbA1c readings can misguide diabetes management strategies.
- Alternative methods are crucial for accurate patient monitoring.
Implications:
- Relying solely on HbA1c for glycaemic control assessment is inadequate for patients with haemoglobinopathies.
- Self-blood glucose monitoring and other methods are vital for guiding DM management in these individuals.
- Clinical practice should adapt to accommodate patients with haemoglobin variants for precise diabetes care.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

